Trophic factor distribution predicts functional recovery in parkinsonian monkeys

Area of Science:

• Neuroscience
• Regenerative Medicine
• Pharmacology

Background:

• Parkinson's disease involves the degeneration of midbrain dopamine neurons.
• Glial cell line-derived neurotrophic factor (GDNF) shows promise for neuroprotection but clinical translation is challenging.
• Optimizing GDNF delivery is crucial for effective Parkinson's disease therapy.

Purpose of the Study:

• To investigate the impact of dose and distribution of GDNF on motor function and dopamine neuron survival in a primate model of Parkinson's disease.
• To evaluate the efficacy of pulsed infusion for convection-enhanced delivery of GDNF.

Main Methods:

• Rhesus monkeys with induced parkinsonism received midbrain infusions of GDNF for 10 weeks.
• GDNF distribution was quantified by measuring the volume of distribution.
• Motor function, dopamine neuron survival (tyrosine hydroxylase positive cells), and neurochemical measures were assessed.

Main Results:

• Significant motor function improvement was observed in GDNF recipients.
• GDNF distribution volume significantly correlated with motor function recovery.
• Increased numbers of dopamine neurons were found in the substantia nigra and ventral tegmental area.
• Higher GDNF doses did not enhance efficacy beyond a critical threshold.

Conclusions:

• Pulsed infusion convection-enhanced delivery of GDNF can improve motor function and dopamine neuron survival in Parkinson's models.
• GDNF tissue distribution is more critical than dose for achieving therapeutic efficacy after a certain threshold.
• These findings support GDNF as a potential therapy for Parkinson's disease, emphasizing optimized delivery strategies.